| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041685 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/09/2006 | US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041667 CCR5 modulators |
| 05/09/2006 | US7041660 2-[2-[3-(2-Guanidinoacetylamino)pyrrolidin-1-ylcarbonyl]-1-methylpyrrolidin-4-ylthio]-6-[(1R)-1-hydroxyethyl]-1-methyl-1-carbapen-2-em-3-carboxylic acid 3 hydrate ethanol; thienamycins; storage stability, shelf life |
| 05/09/2006 | US7041652 administering ascorbic acid, ascorbate or a derivative thereof in combination with quercetin-3-O-glucoside (isoquercetin), quercetin-4'-glucoside, quercetin-3'-glucoside, or quercetin-7-glucoside to increase bioavailability |
| 05/09/2006 | US7041651 Cellular uptake of bioactive agents |
| 05/09/2006 | US7041640 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 05/09/2006 | US7041637 Echinocandin/carbohydrate complexes |
| 05/09/2006 | US7041443 For therapy of porcine subject at risk of infection by, or displaying symptoms of, a porcine reproductive and respiratory syndrome virus infection |
| 05/09/2006 | US7041442 peptides or derivatives of the 65 kD lower matrix phoshpoprotein of HCMV useful for determining whether subjects have been exposed to the virus and for determining the peptide-induced production of interferon- gamma and/or TNF- alpha in CD8+ T cells isolated from subjects |
| 05/09/2006 | US7041300 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 05/09/2006 | US7041295 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 05/09/2006 | US7040314 Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2262668C Inhibitors of cathepsin k |
| 05/09/2006 | CA2257328C Thiazole derivatives |
| 05/09/2006 | CA2199993C Methods of delivering materials into the skin, and compositions used therein |
| 05/09/2006 | CA1341505C Intravenously administered polyclonal immunoglobulin preparation containing igm and method of manufacture |
| 05/04/2006 | WO2006047756A2 Substituted tetracycline compounds |
| 05/04/2006 | WO2006047671A2 4-aminotetracyclines and methods of use thereof |
| 05/04/2006 | WO2006046674A1 Preventive and remedy for hepatitis c virus infection |
| 05/04/2006 | WO2006046552A1 Novel nitrogenous heterocyclic compounds and salts thereof |
| 05/04/2006 | WO2006046527A1 Solid pharmaceutical preparation dissolved in oral cavity |
| 05/04/2006 | WO2006046079A1 Formulations comprising ecteinascidin and a disaccharide |
| 05/04/2006 | WO2006046039A2 Tetracyclic indole derivatives as antiviral agents |
| 05/04/2006 | WO2006046030A2 Tetracyclic indole derivatives as antiviral agents |
| 05/04/2006 | WO2006045828A1 Hiv inhibiting bicyclic pyrimidine derivatives |
| 05/04/2006 | WO2006045615A1 4- (pyrazine-2-yl) -pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors |
| 05/04/2006 | WO2006045613A1 4-methoxymethyl-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors |
| 05/04/2006 | WO2006045475A1 Lactid acid bacteria as probiotic strains and compositions containing same |
| 05/04/2006 | WO2006045474A1 Lactic acid bacteria strains useful against gastrointestinal pathogens and compositions containing same |
| 05/04/2006 | WO2006045473A1 Lactic acid bacteria strains useful against urogenital pathogens and compositions containing same |
| 05/04/2006 | WO2006045156A1 Therapy for multi-drug resistant microorganisms |
| 05/04/2006 | WO2006032525A3 Combinational therapy for treating cancer |
| 05/04/2006 | WO2006030297B1 Taste masked granules comprising clarithromycin, hydrocolloids and a coating |
| 05/04/2006 | WO2006027628A3 Naphthalimide derivatives as antiviral agents |
| 05/04/2006 | WO2006026619A3 Inhibition of viruses using rnase h inhibitors |
| 05/04/2006 | WO2006010040A3 Antibacterial agents |
| 05/04/2006 | WO2006006172A3 Use of anti-amyloid agents for treating and typing pathogen infections |
| 05/04/2006 | WO2005118777A3 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 05/04/2006 | WO2004037972A3 Endogenous retrovirus up-regulated in prostate cancer |
| 05/04/2006 | US20060094767 Antitubercular agent; antibiotic against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria; e.g. (R)-2-methyl-6-nitro-2-(4-(4-(4-trifluoromethoxyphenoxy)piperidin-1-yl)phenoxymethyl)-2,3-dihydroimidazo(2,1-b)oxazole |
| 05/04/2006 | US20060094725 N-heterocyclic derivatives as NOS inhibitors |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094608 Mixture of polyol and insulation agent; heating upon exposure to moisture; for urogenital systems; dysmenorrhea |
| 05/04/2006 | US20060093627 Method of protecting chronic infections |
| 05/04/2006 | US20060093626 Lyophilization; conjugated Streptococcus pneumoniae capsular polysaccharide serotype is adjuvanted with 3-0 deacylated monophosphoryl lipid A (3D-MPL) and devoid of aluminium-based adjuvant |
| 05/04/2006 | US20060093612 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 05/04/2006 | US20060093610 Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS 06 of pseudomonas aeruginosa |
| 05/04/2006 | US20060093609 Vaccine against yersinia comprising one or two antibodies, one specific for yersinia pestis f1-antigen and the other one for yersinia pestis v-antigen |
| 05/04/2006 | US20060093598 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093579 Human recombinant beta-interferon with improved solubility |
| 05/04/2006 | US20060093576 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093574 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 05/04/2006 | US20060093573 Drug composition with antimicrobial activity |
| 05/04/2006 | DE102004052697A1 Pharmazeutische Zubereitungen zur Behandlung von Folgen des Alkoholmissbrauchs, Hepatitis, Pankreatitis, Alzheimererkrankung, Morbus Parkinson, Diabetes, toxischen Nierenerkrankungen, Reperfusionsschäden, der Arteriosklerose sowie als Antidote gegen Umweltgifte und Medikamentenintoxikation Pharmaceutical preparations for the treatment of episodes of alcohol abuse, hepatitis, pancreatitis, Alzheimer's disease, Parkinson's disease, diabetes, toxic kidney disease, reperfusion injury, atherosclerosis and as antidotes against environmental toxins and prescription drug intoxication |
| 05/04/2006 | DE102004052533A1 Particles for use in diagnosis and therapy, especially for binding therapeutic agent for treating e.g. tumors and bacterial, rheumatic, neurologic and thrombotic diseases, have nanocrystalline magnetic core and envelope enclosing core |
| 05/04/2006 | DE102004051023A1 Desoxo-Nonadepsipeptide Deoxo-nonadepsipeptides |
| 05/04/2006 | CA2820140A1 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 05/04/2006 | CA2585418A1 4-aminotetracyclines and methods of use thereof |
| 05/04/2006 | CA2585248A1 Substituted tetracycline compounds |
| 05/04/2006 | CA2585170A1 4-methoxymethyl-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors |
| 05/04/2006 | CA2585113A1 Tetracyclic indole derivatives as antiviral agents |
| 05/04/2006 | CA2585084A1 Tetracyclic indole derivatives as antiviral agents |
| 05/04/2006 | CA2577588A1 Hiv inhibiting bicyclic pyrimidine derivatives |
| 05/03/2006 | EP1652843A1 Amide derivatives |
| 05/03/2006 | EP1652839A2 Drug efflux pump inhibitor |
| 05/03/2006 | EP1652536A1 Wound treatment agent comprising a zeolite iod clathrat |
| 05/03/2006 | EP1652530A1 Drug promoting ceramide transport, base sequence for producing the drug, method of measuring activity of promoting ceramide release and method of measuring activity of promoting intermembrane ceramide transfer |
| 05/03/2006 | EP1652529A2 Antiproliferative and antiviral proteins and peptides |
| 05/03/2006 | EP1652525A1 Anti-coronavirus drug |
| 05/03/2006 | EP1652515A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 05/03/2006 | EP1651762A2 Small interfering rna specific to sub-units $g(a), $g(a)' and $g(b) of the kinase protein ck2, and the applications of the same |
| 05/03/2006 | EP1651643A2 Bicyclic compounds and compositions as pdf inhibitors |
| 05/03/2006 | EP1651639A1 Benzofuran derivatives and their use in the treatment of microbial infections |
| 05/03/2006 | EP1651631A1 Bicyclic imidazol derivatives against flaviviridae |
| 05/03/2006 | EP1651612A1 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 05/03/2006 | EP1651271A2 Compositions and methods for treating coronavirus infection and sars |
| 05/03/2006 | EP1651255A1 Topical veterinary compositions and methods for the treatment and prevention of infection |
| 05/03/2006 | EP1651244A1 Use of root extracts from Pelargonium sidoides and Pelargonium Reniforme |
| 05/03/2006 | EP1651226A2 Ubiquitin ligase inhibitors and methods related thereto |
| 05/03/2006 | EP1651212A1 Thio-substituted phenbutazone compounds as anti-inflammatory, anti-viral and immunomodulatory agents |
| 05/03/2006 | EP1651202A1 Compositions containing prodrugs of florfenicol and methods of use |
| 05/03/2006 | EP1651198A2 Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases |
| 05/03/2006 | EP1499606B1 3, 4-dihydroquinolin-2(1h)-one compounds as nr2b receptor antagonists |
| 05/03/2006 | EP1419119B1 Water-insoluble, antimicrobial silicate glass and use thereof |
| 05/03/2006 | EP1389129A4 Methods of treating respiratory conditions |
| 05/03/2006 | EP1313422A4 Non-hormonal vaginal contraceptive |
| 05/03/2006 | EP1248771B1 Method for preparing hydroxypicolinic acid derivatives |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1232748B1 Use of substituted nitrobenzene derivatives for the treatment of diseases caused by bacteria, fungi and viruses |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1194404B1 Inhibitors of aspartyl protease |
| 05/03/2006 | EP1185273B1 Antifungal oral composition containing itraconazole and process for preparing same |
| 05/03/2006 | EP1143976B1 Beta-d-2', 3' -didehydro-2', 3' -dideoxy-5-fluorocytidine for use in the treatment of hiv infections |
| 05/03/2006 | EP1139755B1 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 05/03/2006 | EP1104309B1 Co-lyophilized complex comprising a nucleic acid vector and a formulating agent |